×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 0701: GENERIC DRUG DEVELOPMENT IN CHINA (PART I)
Session Chair(s)
Yi REN, PhD, MBA
General Manager
Nanjing Medichem Bio-Pharmaceutical Development Co. , China
Session 0701: GENERIC DRUG DEVELOPMENT IN CHINA (PART I)
Speaker(s)
Current Status of Generic Drug Consistency Evaluation
Bo LI
Food and Drug Administration, Hunan Province, China
Deputy Division Director
Effect and Implementation Status of No. EU62 ~ Chinese version only
Zuojun Dong
Zhejiang University of Technology, China
Scientific Approach in Quality Consistency Evaluation of Generic Drug
Daniel Song
Janssen Pharmaceutical Companies, Johnson & Johnson, China
Have an account?